1
/
of
0
FDA Drug Approval, N020080, IMITREX STATDOSE
FDA Drug Approval, N020080, IMITREX STATDOSE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 020080
Company: GLAXOSMITHKLINE
Drug Name: IMITREX STATDOSE
Active Ingredients: SUMATRIPTAN SUCCINATE
Strength: EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Dosage Form/Route: INJECTABLE;SUBCUTANEOUS
Action Date: 12/28/1992
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Company: GLAXOSMITHKLINE
Drug Name: IMITREX STATDOSE
Active Ingredients: SUMATRIPTAN SUCCINATE
Strength: EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Dosage Form/Route: INJECTABLE;SUBCUTANEOUS
Action Date: 12/28/1992
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details